ArticleJournal for immunotherapy of cancer2022

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer.

Ming Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.